WHO Drug Information Vol. 24, No. 4, 2010

Proposed INN: List 104 WHO Drug Information, Vol. 24, No. 4, 2010luseogliflozinumluseogliflozinluséogliflozineluseogliflozina(2S,3R,4R,5S,6R)-2-{5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl}-6-(hydroxymethyl)thiane-3,4,5-triolantidiabetic(2S,3R,4R,5S,6R)-2-{5-[(4-éthoxyphényl)méthyl]-2-méthoxy-4-méthylphényl}-6-(hydroxyméthyl)thiane-3,4,5-triolantidiabétique(2S,3R,4R,5S,6R)-2-{5-[(4-etoxifenil)metil]-4-metilfenil-2-metoxi}-6-(hidroximetil)tiano-3,4,5-triolhipoglucemianteC 23 H 30 O 6 S 898537-18-3OHOCH 3CH 3OCH 3HOOHSOHlusutrombopagumlusutrombopaglusutrombopaglusutrombopag(2E)-3-{2,6-dichloro-4-[(4-{3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl}-1,3-thiazol-2-yl)carbamoyl]phenyl}-2-methylprop-2-enoic acidthrombopoietin receptor agonistacide (2E)-3-{2,6-dichloro-4-[(4-{3-[(1S)-1-(hexyloxy)éthyl]-2-méthoxyphényl}-1,3-thiazol-2-yl)carbamoyl]phényl}-2-méthylprop-2-énoïqueagoniste du récepteur de la thrombopoïétineácido (2E)-3-{2,6-dicloro-4-[(4-{3-[(1S)-1-(hexiloxi)etil]-2-metoxifenil}-1,3-tiazol-2-il)carbamoil]fenil}-2-metilprop-2-enoicoagonista de los receptores de trombopoyetinaC 29 H 32 Cl 2 N 2 O 5 S 1110766-97-6NSNHOClCH 3OCH 3CO 2 HH 3 COCH 3HCl380